B. Riley Wealth Advisors’s Accentia Biopharmaceuticals ABPI Stock Holding History

B. Riley Wealth Advisors’s Portfolio ABPI Stock Details ABPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-15,000	Closed	–	–	2684
2014 Q4	$0	Buy	+15,000	New	–	﹤0.01%	3852

B. Riley Wealth Advisors's ABPI Position: Q1 2015 in Review

B. Riley Wealth Advisors sold out of Accentia Biopharmaceuticals (ABPI) in Q1 2015, closing a stake of 15,000 shares.

B. Riley Wealth Advisors first reported a position in ABPI in Q4 2014 and held it in 1 quarter. The position peaked at $0 in Q4 2014. 1 fund tracked by Wall St. Rank holds ABPI as of Q1 2015.

B. Riley Wealth Advisors reported no remaining Accentia Biopharmaceuticals position as of Q1 2015 after selling out during the quarter.
B. Riley Wealth Advisors sold 15,000 Accentia Biopharmaceuticals shares in Q1 2015.
B. Riley Wealth Advisors first reported a position in Accentia Biopharmaceuticals in Q4 2014 and held it in 1 quarter.
B. Riley Wealth Advisors's Accentia Biopharmaceuticals position peaked at $0 in Q4 2014.
1 fund tracked by Wall St. Rank held Accentia Biopharmaceuticals as of Q1 2015.

Based on B. Riley Wealth Advisors's 13F filing for Q1 2015, filed 14 May 2015.